Desai Mehul J, Hargens Liesl M, Breitenfeldt Maria D, Doth Alissa H, Ryan Michael P, Gunnarsson Candace, Safriel Yair
*International Spine, Pain & Performance Center, Washington, DC †Medtronic, plc., Minneapolis, MN ‡CTI Clinical Trial & Consulting Services, Cincinnati, OH; and §Pharmascan, Wilmington, DE and University of South Florida, Clearwater, FL.
Spine (Phila Pa 1976). 2015 May 1;40(9):E531-7. doi: 10.1097/BRS.0000000000000805.
Analysis of use of magnetic resonance imaging (MRI) in the chronic back and leg pain spinal cord stimulation (SCS)-implanted population was conducted using a propensity-matched cohort population.
To project the percentage of patients with SCS expected to need at least 1 MRI within 5 years of implant.
Patients experiencing pain, including those who underwent implantation with SCS systems, are likely to have comorbidities and ongoing pain issues that may require diagnostic imaging. MRI is the most common diagnostic imaging modality for evaluating patients with new or worsening low back pain. However, patients with SCS are typically excluded from receiving MRI because of the safety risks related to the interactions of MRI fields and implantable devices.
To provide an accurate estimate of the need for MRI in the SCS-implanted population, Truven Health MarketScan Commercial Claims and Medicare Supplemental databases were used to perform analysis of SCS-implanted patients propensity score matched to a nonimplanted population-based cohort. Four years of paid and adjudicated claims data were used to determine the magnetic resonance (MR) images received, which was exponentially projected to estimate MRI within 5 and 10 years of implant.
Approximately 82% to 84% of SCS-implanted patients are expected to need at least 1 MRI within 5 years of implant. Furthermore, 59% to 74% of patients will require nonspine MRI within 10 years.
There is a high need for MRI in this chronic back and leg pain SCS population, with a significant portion being completed on locations outside of the spine. This analysis highlights a need for MRI-conditional SCS devices that grant access of patients with SCS to this imaging modality.
采用倾向匹配队列人群对慢性腰腿痛脊髓刺激(SCS)植入人群中磁共振成像(MRI)的使用情况进行分析。
预测SCS植入患者在植入后5年内预计至少需要进行1次MRI检查的比例。
经历疼痛的患者,包括接受SCS系统植入的患者,可能患有合并症和持续的疼痛问题,这可能需要进行诊断性成像检查。MRI是评估新发或加重的下腰痛患者最常用的诊断性成像方式。然而,由于MRI场与可植入设备相互作用的安全风险,SCS患者通常被排除在接受MRI检查之外。
为了准确估计SCS植入人群对MRI的需求,使用Truven Health MarketScan商业理赔和医疗保险补充数据库对与非植入人群队列进行倾向得分匹配的SCS植入患者进行分析。使用四年的付费和已裁决理赔数据来确定所接受的磁共振(MR)图像,并通过指数预测来估计植入后5年和10年内的MRI检查需求。
预计约82%至84%的SCS植入患者在植入后5年内至少需要进行1次MRI检查。此外,59%至74%的患者在10年内需要进行非脊柱MRI检查。
在这个慢性腰腿痛SCS人群中对MRI有很高的需求,其中很大一部分是在脊柱以外的部位进行的。该分析强调了对MRI条件性SCS设备的需求,以使SCS患者能够接受这种成像检查。
3级。